Biblio
Export 155 results:
[ Author
Filters: First Letter Of Last Name is K [Clear All Filters]
“Association between Plasma Ceramides and Phosphatidylcholines and Hippocampal Brain Volume in Late Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 3, pp. 809-817, 2017.
, “Anemia in Association with Cognitive Impairment: A Systematic Review and Meta-Analysis.”, J Alzheimers Dis, vol. 72, no. 3, pp. 803-814, 2019.
, “Distinctive Resting State Network Disruptions Among Alzheimer's Disease, Subcortical Vascular Dementia, and Mixed Dementia Patients.”, J Alzheimers Dis, vol. 50, no. 3, pp. 709-18, 2016.
, “Inhibition of Cholesterol Biosynthesis Reduces γ-Secretase Activity and Amyloid-β Generation.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1057-68, 2016.
, “18F-AV-1451 PET Imaging in Three Patients with Probable Cerebral Amyloid Angiopathy.”, J Alzheimers Dis, vol. 57, no. 3, pp. 711-716, 2017.
, “Vascular Effects on Depressive Symptoms in Cognitive Impairment.”, J Alzheimers Dis, vol. 65, no. 2, pp. 597-605, 2018.
, “Exposure to General Anesthesia and Risk of Dementia: A Nationwide Population-Based Cohort Study.”, J Alzheimers Dis, vol. 63, no. 1, pp. 395-405, 2018.
, “Discovering New Genes in the Pathways of Common Sporadic Neurodegenerative Diseases: A Bioinformatics Approach.”, J Alzheimers Dis, vol. 51, no. 1, pp. 293-312, 2016.
, “Brain Atrophy of Secondary REM-Sleep Behavior Disorder in Neurodegenerative Disease.”, J Alzheimers Dis, vol. 52, no. 3, pp. 1101-9, 2016.
, “Effect of Cilostazol on Incident Dementia in Elderly Men and Women with Ischemic Heart Disease.”, J Alzheimers Dis, vol. 63, no. 2, pp. 635-644, 2018.
, “The Role of Amyloid, Tau, and APOE Genotype on the Relationship Between Informant-Reported Sleep Disturbance and Alzheimer's Disease Risks.”, J Alzheimers Dis, vol. 87, no. 4, pp. 1567-1580, 2022.
, “Visual Rating of Posterior Atrophy as a Marker of Progression to Dementia in Mild Cognitive Impairment Patients.”, J Alzheimers Dis, vol. 55, no. 1, pp. 137-146, 2017.
, “A Nomogram for Predicting Amyloid PET Positivity in Amnestic Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 66, no. 2, pp. 681-691, 2018.
, “An International Comparative Study on Driving Regulations on People with Dementia.”, J Alzheimers Dis, vol. 56, no. 3, pp. 1007-1014, 2017.
, “Feasibility and Efficacy of Intra-Arterial Administration of Embryonic Stem Cell Derived-Mesenchymal Stem Cells in Animal Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 76, no. 4, pp. 1281-1296, 2020.
, “The Role of Cerebrovascular Disease on Cognitive and Functional Status and Psychosis in Severe Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 1, pp. 381-389, 2017.
, “Effect of Fluvoxamine on Amyloid-β Peptide Generation and Memory.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1777-1787, 2018.
, “Genetic Influences on Plasma Homocysteine Levels in African Americans and Yoruba Nigerians.”, J Alzheimers Dis, vol. 49, no. 4, pp. 991-1003, 2016.
, “Post-Translational Chemical Modifications of Amyloid-β Peptides by 4-Hydroxy-2-Nonenal.”, J Alzheimers Dis, 2023.
, “A Blood Test for Alzheimer's Disease: Progress, Challenges, and Recommendations.”, J Alzheimers Dis, vol. 64, no. s1, pp. S289-S297, 2018.
, “Impact of Depressive Symptoms on Conversion from Mild Cognitive Impairment Subtypes to Alzheimer's Disease: A Community-Based Longitudinal Study.”, J Alzheimers Dis, vol. 51, no. 2, pp. 405-15, 2016.
, “18F-FDG Is a Superior Indicator of Cognitive Performance Compared to 18F-Florbetapir in Alzheimer's Disease and Mild Cognitive Impairment Evaluation: A Global Quantitative Analysis.”, J Alzheimers Dis, vol. 70, no. 4, pp. 1197-1207, 2019.
, “Improved Differential Diagnosis of Alzheimer's Disease by Integrating ELISA and Mass Spectrometry-Based Cerebrospinal Fluid Biomarkers.”, J Alzheimers Dis, vol. 67, no. 2, pp. 639-651, 2019.
, “Positive and Negative Experiences of Social Support and Risk of Dementia in Later Life: An Investigation Using the English Longitudinal Study of Ageing.”, J Alzheimers Dis, vol. 58, no. 1, pp. 99-108, 2017.
, “Cannabidiol Ameliorates Cognitive Function via Regulation of IL-33 and TREM2 Upregulation in a Murine Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 80, no. 3, pp. 973-977, 2021.
,